1/8
10:04 am
tecx
Tectonic Therapeutic (NASDAQ:TECX) was given a new $60.00 price target on by analysts at Truist Financial Corporation.
Low
Report
Tectonic Therapeutic (NASDAQ:TECX) was given a new $60.00 price target on by analysts at Truist Financial Corporation.
12/10
02:22 pm
tecx
Tectonic Therapeutic (TECX): LifeSci Capital Reiterates Buy Rating [Yahoo! Finance]
Low
Report
Tectonic Therapeutic (TECX): LifeSci Capital Reiterates Buy Rating [Yahoo! Finance]
12/1
08:10 am
tecx
Tectonic Therapeutic to Participate in December Investor Conferences [Yahoo! Finance]
Medium
Report
Tectonic Therapeutic to Participate in December Investor Conferences [Yahoo! Finance]
12/1
08:00 am
tecx
Tectonic Therapeutic to Participate in December Investor Conferences
Medium
Report
Tectonic Therapeutic to Participate in December Investor Conferences
11/18
02:25 am
tecx
Tectonic: Strong Buy On Positive Phase 1b TX45 Data And 2026 Inflection Point [Seeking Alpha]
Low
Report
Tectonic: Strong Buy On Positive Phase 1b TX45 Data And 2026 Inflection Point [Seeking Alpha]
11/6
11:31 pm
tecx
Tectonic Therapeutic GAAP EPS of -$1.02 beats by $0.05 [Seeking Alpha]
Low
Report
Tectonic Therapeutic GAAP EPS of -$1.02 beats by $0.05 [Seeking Alpha]
11/6
04:01 pm
tecx
Tectonic Therapeutic Announces Third Quarter 2025 Financial Results and Recent Business Highlights
Low
Report
Tectonic Therapeutic Announces Third Quarter 2025 Financial Results and Recent Business Highlights
10/29
04:01 pm
tecx
Tectonic Therapeutic Announces Positive Topline Data from Phase 1b Part B Clinical Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFrEF
Medium
Report
Tectonic Therapeutic Announces Positive Topline Data from Phase 1b Part B Clinical Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFrEF
10/25
12:12 pm
tecx
Tectonic Therapeutic (NASDAQ:TECX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Tectonic Therapeutic (NASDAQ:TECX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.